<--- Back to Details
First PageDocument Content
Date: 2016-06-05 05:57:06

Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in patients (pts) with recurrent platinum-sensitive ovarian cancer (OC) Roisin O’Cearbhaill1, Scott McM

Add to Reading List

Source URL: s3.amazonaws.com

Download Document from Source Website

File Size: 751,37 KB

Share Document on Facebook

Similar Documents